Novel Anti-platelet Agents for the Treatment of Stable Angina Pectoris

E-ISSN： 1873-4286|19|9|1581-1586

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.9, 2013-03, pp. : 1581-1586

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stable Angina Pectoris: Current Medical Treatment

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1569-1580

Bentham Science Publishers

Access to resources Recommend Favorite

Trimetazidine for stable angina pectoris

By Cross H.R.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 857-875

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Hot Topics: Stable Angina Pectoris: Novel Therapeutic Insights)

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-01 ,pp. : 1549-1549

Bentham Science Publishers

Access to resources Recommend Favorite

Ranolazine extended release is a useful adjunct in the treatment of chronic stable angina pectoris

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 1, 2007-01 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Insight to the Pathophysiology of Stable Angina Pectoris

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1593-1600

Bentham Science Publishers

Access to resources Recommend Favorite